The FDA approved Vertex Pharmaceuticals’ Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, ...

While Tapentadol is a serious habit-forming opioid-based drug, Pregabalin has become a headache in Punjab as it is ...

Sequentially, revenue from operations grew by 2.9 per cent, whereas profit after tax (PAT) fell by 4.5 per cent ...

Patient monitors, used in both healthcare facilities and home settings, display vital patient information including ...

Domestic formulation sales increased by 13.8 per cent to Rs 4,300.4 crore Y-o-Y, representing 32 per cent of the company's ...

Robert F. Kennedy Jr. said he would hire a Native American to serve in his central office if confirmed as the nation's top ...

Dr. Mrinal M Gounder emphasizes the complexity of breast cancer and the necessity for unique treatments for its many variants ...

The US Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows ...

Following the GBS disease outbreak with cases reported in clusters from Sinhgad Road, Nande Village, Kirkitwadi, Dhayari and DSK Vishwa amongst other areas the State government and PMC issued directio ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction ...

The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...

The -NORC poll shows about half of Americans “strongly” or “somewhat” favor having the federal programs Medicare and Medicaid cover weight-loss drugs for people who have obesity, while about 2 in 10 ...